Diabetes, Obesity and Metabolism

Leptin and its metabolic interactions - an update
pp. 973-993(21)
Authors: Anubhuti,; Arora, Sarika

GLP-1: physiological effects and potential therapeutic applications
pp. 994-1003(10)
Authors: Aaboe, Kasper; Krarup, Thure; Madsbad, Sten; Holst, Jens Juul

Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation
pp. 1004-1011(8)
Author: Brinton, Eliot A.

Body composition analysis by leg-to-leg bioelectrical impedance and dual-energy X-ray absorptiometry in non-obese and obese individuals
pp. 1012-1018(7)
Authors: Boneva-Asiova,; Boyanov,

Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives
pp. 1019-1028(10)
Authors: Hulstrøm,; Højlund,; Vinten,; Beck-Nielsen,; Levin,

Short-term β-adrenergic regulation of leptin, adiponectin and interleukin-6 secretion in vivo in lean and obese subjects
pp. 1029-1038(10)
Authors: Goossens,; Jocken,; van Baak,; Jansen,; Saris,; Blaak,

Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?
pp. 1039-1046(8)
Authors: Kusaka,; Nagasaka,; Horie,; Ishibashi,

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea
pp. 1047-1056(10)
Authors: Garber,; Foley,; Banerji,; Ebeling,; Gudbjörnsdottir,; Camisasca,; Couturier,; Baron,

Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited
pp. 1057-1061(5)
Authors: Burkey,; Hoffmann,; Hassiepen,; Trappe,; Juedes,; Foley,

Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes
pp. 1062-1073(12)
Authors: Wycherley,; Brinkworth,; Noakes,; Buckley,; Clifton,

Rebaudioside A directly stimulates insulin secretion from pancreatic beta cells: a glucose-dependent action via inhibition of ATP-sensitive K⁺-channels
pp. 1074-1085(12)
Authors: Abudula,; Matchkov,; Jeppesen,; Nilsson,; Aalkjær,; Hermansen,

Effect of raisin consumption on oxidative stress and inflammation in obesity
pp. 1086-1096(11)
Authors: Rankin,; Andreae,; Oliver Chen,; O'Keefe,

Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation
pp. 1097-1104(8)
Authors: Ortiz-Andrade,; Sánchez-Salgado,; Navarrete-Vázquez,; Webster,; Binnie,; García-Jiménez,; León-Rivera,; Cigarroa-Vázquez,; Villalobos-Molina,; Estrada-Soto,

Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects
pp. 1105-1113(9)
Authors: Becker,; Frick,; Teichert,; Nosek,; Heinemann,; Heise,; Rave,

Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia
pp. 1114-1124(11)
Authors: Scherbaum,; Schweizer,; Mari,; Nilsson,; Lalanne,; Wang,; Dunning,; Foley,

Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trial
pp. 1125-1127(3)

SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics
pp. 1128-1129(2)

Response to Professor John A Tayek's letter on SUR receptor activity
pp. 1129-1130(2)

News and Views
pp. 1131-1134(4)
Author: Idris, Iskandar